Drug Profile
LJ 102
Alternative Names: HER 102; LJ-102Latest Information Update: 07 Jan 2022
Price :
$50
*
At a glance
- Originator Hervana
- Class Contraceptives; Probiotics
- Mechanism of Action Bacteria replacements; Vaginal microbiome modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Pregnancy
Most Recent Events
- 28 Feb 2020 No recent reports of development identified for preclinical development in Pregnancy(Prevention) in Israel (Vaginal, Suppository)
- 02 Feb 2018 LJ 102 is still undergoing preclinical trials in Pregnancy (Prevention) in Israel (Vaginal, Once-monthly)
- 02 Feb 2018 Discontinued - Preclinical for Pregnancy (Prevention) in Israel (Vaginal, Bi-monthly)